Skip to main content
Clinical Trials/NCT00163696
NCT00163696
Unknown
N/A

Measurements of Inhomogeneity of the Small Airway With Patients With Cystic Fibrosis, Asthma and Bronchiolitis Obliterans Syndrome (Post Transplant) Using the Multi Breath Nitrogen Washout Technique

Bayside Health1 site in 1 country90 target enrollmentSeptember 2004

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cystic Fibrosis
Sponsor
Bayside Health
Enrollment
90
Locations
1
Last Updated
18 years ago

Overview

Brief Summary

The researchers are investigating a novel technique, the multi breath nitrogen washout technique, to measure airway changes in various respiratory diseases.

Detailed Description

It is well documented that there are significant ventilatory changes in respiratory diseases such as cystic fibrosis, asthma and the onset of bronchiolitis obliterans syndrome (BOS) following chronic rejection of lung transplantation. At present, we use measures such as spirometry and lung biopsies to determine the changes of airway function and disease severity. Our aim is to develop a novel technique called the multi breath nitrogen washout (MBNW) which we believe is able to measure the inhomogeneity of ventilation in both the larger airways (conductive region, generation 1 - 16) as well as the smaller airways (acinar region 17 - 23). Our belief is that these measurements are much more subtle than current techniques and will be more sensitive in measuring large and small airway changes in disease. The MBNW can also give us an insight as to which particular zones of the lung are affected in differing respiratory disease. For example, it is believed that BOS begins at the distal portion of the lung (acinar region) and proceeds towards the proximal zone (conductive). However, at present no current techniques can differentiate between damage to the acinar zone and the conductive zone or indeed accurately measure small airway (acinar zone) function. We believe the the MBNW has the capacity to do so.

Registry
clinicaltrials.gov
Start Date
September 2004
End Date
TBD
Last Updated
18 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Bayside Health

Eligibility Criteria

Inclusion Criteria

  • Doctor diagnosed cystic fibrosis, asthma
  • Lung transplant recipient

Exclusion Criteria

  • Smoke history of less than 10 pack years

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials